ARCHIVES

Pao Named Director of Department Of Hematology And Oncology At Vanderbilt University

This article is from The Cancer Letter archive.

Vol. 37 No. 36 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

Outcome Of Prostate Cancer Surgery Depends On Experience Of Surgeon

August 31, 2007

DCPC Board Will Consider Revised Concepts For CPRUs

September 18, 1987

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

March 4, 1988

Funding opportunities listed.

March 26, 2004

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006